Latest Breaking News On - Sanofi china - Page 1 : comparemela.com

France s Sanofi Logs 6 2% Jump in China Revenue in First Quarter on 2024-05-07

France s Sanofi Logs 6 2% Jump in China Revenue in First Quarter on 2024-05-07
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Shi wangFrance generalZhu limingemailNews networkNational medical products administrationYicai media groupShanghai media groupSanofi chinaYicai globalYicai media

2024 forecast: Big Pharma reworks China strategy, and job cuts are part of it

2024 forecast: Big Pharma reworks China strategy, and job cuts are part of it
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United kingdomLuke mielsKeyuan pharmaDaiichi sankyo enhertuJustin wangChina national reimbursement drug listBig pharmaShanghai pharmaChongqing zhifei biological productsPrevenar chinaSanofi chinaNational reimbursement drug listDaiichi sankyoGilead science trodelvy

Genomicare Biotechnology: GenomiCare Biotechnology Appoints Dr Shusen Liu as Chief Medical Officer

Dr. Liu will lead real world data (RWD) strategy and growth of global biopharma company partnershipsHAVERFORD, Pa., Jan. 20, 2022 (GLOBE NEWSWIRE) GenomiCare Biotechnology, a leader in precision medicine

United statesQiang xuKostenloser wertpapierhandelPharmacoepidemiology asia pacificShusen liuShanghai medical universityFudan universityDigital china healthCare biotechnologyChief medicalGenomicare biotechnologyChief medical officerReal world evidenceSanofi chinaPharmacoepidemiology asia pacific unitVice president

Investegate |Genomicare Biotechnology Announcements | Genomicare Biotechnology: GenomiCare Biotechnology Appoints Dr Shusen Liu as Chief Medical Officer

Investegate announcements from Genomicare Biotechnology, GenomiCare Biotechnology Appoints Dr. Shusen Liu as Chief Medical Officer

United statesQiang xuPharmacoepidemiology asia pacificShusen liuShanghai medical universityFudan universityDigital china healthGenomicare biotechnology appointsChief medicalCare biotechnologyGenomicare biotechnologyChief medical officerReal world evidenceSanofi chinaPharmacoepidemiology asia pacific unitVice president

GenomiCare Biotechnology Appoints Dr Shusen Liu as Chief Medical Officer

Dr. Liu will lead real world data strategy and growth of global biopharma company partnershipsHAVERFORD, Pa., Jan. 20, 2022 GenomiCare Biotechnology, a leader in precision medicine of Chinese.

Qiang xuPharmacoepidemiology asia pacificShusen liuShanghai medical universityFudan universityDigital china healthCare biotechnologyChief medicalGenomicare biotechnologyChief medical officerReal world evidenceSanofi chinaPharmacoepidemiology asia pacific unitVice presidentChief medical evidence officer